Event Sponsors
We would like to extend a very special thank you to our sponsors for their support of our 7th Annual Pacific Northwest Symposium.
This event is endorsed by
Course Information
Conference: 1 day – multiplatform meeting for in-person & virtual participation covering the Northwest with an estimated 200 attendees. If an in-person meeting cannot be safely conducted, an exclusively virtual conference platform will be offered.
Intended Audience
This activity was developed for gastroenterologists, advanced nurse practitioners, physician assistants, gastroenterology nurses, pharmacists, and surgeons involved in the care of patients with IBD.
Learning Objectives
At the conclusion of this learning activity, participants will do the following:
- Analyze the currently available tools to stratify the risk of patients developing complicated IBD vs. mild IBD at diagnosis and the subsequent implications on treatment goals and strategies.
- Describe the comparative efficacy of the currently available therapies and the rationale for optimal positioning of these agents in IBD today.
- Outline the goals of IBD care and incorporate the latest concepts, including treat-to-target in IBD clinical practice to optimize patient outcomes.
- Identify the current endoscopic assessment tools and scoring systems and their practical application in IBD management.
- Assess the latest evidence regarding the role of therapeutic drug monitoring, proactive and reactive, to optimize response to biologic therapy in patients with IBD.
- Recognize the various medical and surgical challenges for patients who receive an ileoanal pouch and the latest management recommendations.
- Review our current understanding of the microbiome in IBD and microbiome manipulation in the management of IBD today.
- Discuss the newly approved and soon to be approved biologic and non-biologic therapies for IBD, including the risks, efficacy, and special considerations when utilizing these therapies.
Accreditation and Certification
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Annenberg Center for Health Sciences at Eisenhower and IBDHorizons. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Physicians
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 6.5 contact hours may be earned for successful completion of this activity.
Pharmacists
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-0797-9999-22-004-L01-P. This program is designated for up to 6.5 contact hours (0.65 CEUs) of continuing pharmacy education credit.
IBDHorizons Privacy Policy
https:/ibdhorizons.org/privacy-policy
Annenberg Center for Health Sciences Privacy Policy
Annenberg Center for Health Sciences Privacy Policy: Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at https://annenberg.net/pages/privacyPolicy.php
;
